These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


213 related items for PubMed ID: 15838798

  • 21. Association between common Toll-like receptor 4 mutations and severe respiratory syncytial virus disease.
    Tal G, Mandelberg A, Dalal I, Cesar K, Somekh E, Tal A, Oron A, Itskovich S, Ballin A, Houri S, Beigelman A, Lider O, Rechavi G, Amariglio N.
    J Infect Dis; 2004 Jun 01; 189(11):2057-63. PubMed ID: 15143473
    [Abstract] [Full Text] [Related]

  • 22. Human genetics and respiratory syncytial virus disease: current findings and future approaches.
    Choi EH, Lee HJ, Chanock SJ.
    Curr Top Microbiol Immunol; 2013 Jun 01; 372():121-37. PubMed ID: 24362687
    [Abstract] [Full Text] [Related]

  • 23. Influence of promoter variants of interleukin-10, interleukin-9, and tumor necrosis factor-alpha genes on respiratory syncytial virus bronchiolitis.
    Hoebee B, Bont L, Rietveld E, van Oosten M, Hodemaekers HM, Nagelkerke NJ, Neijens HJ, Kimpen JL, Kimman TG.
    J Infect Dis; 2004 Jan 15; 189(2):239-47. PubMed ID: 14722888
    [Abstract] [Full Text] [Related]

  • 24. Genetic predisposition to wheeze following respiratory syncytial virus bronchiolitis.
    Goetghebuer T, Isles K, Moore C, Thomson A, Kwiatkowski D, Hull J.
    Clin Exp Allergy; 2004 May 15; 34(5):801-3. PubMed ID: 15144474
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Proteins involved in extracellular matrix dynamics are associated with respiratory syncytial virus disease severity.
    Schuurhof A, Bont L, Hodemaekers HM, de Klerk A, de Groot H, Hofland RW, van de Pol AC, Kimpen JL, Janssen R.
    Eur Respir J; 2012 Jun 15; 39(6):1475-81. PubMed ID: 22267765
    [Abstract] [Full Text] [Related]

  • 27. Functionally relevant variations of the interleukin-10 gene associated with antineutrophil cytoplasmic antibody-negative Churg-Strauss syndrome, but not with Wegener's granulomatosis.
    Wieczorek S, Hellmich B, Arning L, Moosig F, Lamprecht P, Gross WL, Epplen JT.
    Arthritis Rheum; 2008 Jun 15; 58(6):1839-48. PubMed ID: 18512809
    [Abstract] [Full Text] [Related]

  • 28. Monocyte interleukin-12 production is inversely related to duration of respiratory failure in respiratory syncytial virus bronchiolitis.
    Bont L, Kavelaars A, Heijnen CJ, van Vught AJ, Kimpen JL.
    J Infect Dis; 2000 May 15; 181(5):1772-5. PubMed ID: 10823782
    [Abstract] [Full Text] [Related]

  • 29. Type 1 and type 2 cytokine imbalance in acute respiratory syncytial virus bronchiolitis.
    Legg JP, Hussain IR, Warner JA, Johnston SL, Warner JO.
    Am J Respir Crit Care Med; 2003 Sep 15; 168(6):633-9. PubMed ID: 12773328
    [Abstract] [Full Text] [Related]

  • 30. A comparison of epidemiologic and immunologic features of bronchiolitis caused by influenza virus and respiratory syncytial virus.
    Garofalo RP, Hintz KH, Hill V, Patti J, Ogra PL, Welliver RC.
    J Med Virol; 2005 Feb 15; 75(2):282-9. PubMed ID: 15602730
    [Abstract] [Full Text] [Related]

  • 31. Genetic susceptibility to respiratory syncytial virus bronchiolitis in preterm children is associated with airway remodeling genes and innate immune genes.
    Siezen CL, Bont L, Hodemaekers HM, Ermers MJ, Doornbos G, Van't Slot R, Wijmenga C, Houwelingen HC, Kimpen JL, Kimman TG, Hoebee B, Janssen R.
    Pediatr Infect Dis J; 2009 Apr 15; 28(4):333-5. PubMed ID: 19258923
    [Abstract] [Full Text] [Related]

  • 32. Immunomodulatory constituents of human milk change in response to infant bronchiolitis.
    Bryan DL, Hart PH, Forsyth KD, Gibson RA.
    Pediatr Allergy Immunol; 2007 Sep 15; 18(6):495-502. PubMed ID: 17680907
    [Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Lipopolysaccharide hyporesponsiveness as a risk factor for intensive care unit hospitalization in infants with respiratory syncitial virus bronchiolitis.
    Mandelberg A, Tal G, Naugolny L, Cesar K, Oron A, Houri S, Gilad E, Somekh E.
    Clin Exp Immunol; 2006 Apr 15; 144(1):48-52. PubMed ID: 16542364
    [Abstract] [Full Text] [Related]

  • 39. RANTES promoter gene polymorphisms and susceptibility to severe respiratory syncytial virus-induced bronchiolitis.
    Amanatidou V, Sourvinos G, Apostolakis S, Neonaki P, Tsilimigaki A, Krambovitis E, Spandidos DA.
    Pediatr Infect Dis J; 2008 Jan 15; 27(1):38-42. PubMed ID: 18162936
    [Abstract] [Full Text] [Related]

  • 40. Association between surfactant protein A gene locus and severe respiratory syncytial virus infection in infants.
    Löfgren J, Rämet M, Renko M, Marttila R, Hallman M.
    J Infect Dis; 2002 Feb 01; 185(3):283-9. PubMed ID: 11807709
    [Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 11.